Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trials of New Chemopreventive Agents-25434001
University. of Wisconsin System
Search grants from University. of Wisconsin System
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Barriers to Alcohol, Drug and PTSD Treatment for Returning National Guard
Genomics
FoxP3 Regulatory Network mRNA Profiles and Human Renal Transplant Outcomes
Remodelling and Elimination of Synapses
RI: Small: Designing Preferences, Beliefs, and Identities for Artificial Intelligence
Recently added grants:
Catestatin improves glucose homeostasis and insulin sensitivity in diet-induced obese mice
Mitochondrial-Targeted Antioxidant-Encapsulating Nanoparticles as a Promising Therapeutic Strategy in Regulating Outflow Resistance
Interaction of GCSF with the Endocannabinoid System in Promoting Brain Repair
Lymphangiogenesis in the pathogenesis of Acute Kidney Injury
Pathogenic role of thrombospondin-1 in acute and chronic liver failure
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA034001-005
Application #
6688639
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University. of Wisconsin System
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase II Clinical Trials of New Chemopreventive Agents-25434001
/ University. of Wisconsin System
NIH 2002
N01 CA
Phase II Clinical Trials of New Chemopreventive Agents-25434001
/ University. of Wisconsin System
Comments
Be the first to comment on this grant